Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$789M |
| 3 |
Amazon
AMZN
|
+$651M |
| 4 |
NVIDIA
NVDA
|
+$442M |
| 5 |
Tesla
TSLA
|
+$423M |
Top Sells
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
Aon
AON
|
+$184M |
| 3 |
JD.com
JD
|
+$173M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$139M |
Sector Composition
| 1 | Technology | 26.23% |
| 2 | Healthcare | 13.24% |
| 3 | Financials | 12.99% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Alpha Teknova
TKNO
$238M
| $2.44M | ﹤0.01% |
119,213
+38,730
| +48% | +$793K |
|
3277
Wave Life Sciences
WVE
$1.11B
| $2.44M | ﹤0.01% |
776,963
+147,461
| +23% | +$463K |
|
3278
ZipRecruiter
ZIP
$419M
| $2.44M | ﹤0.01% |
97,692
+21,271
| +28% | +$530K |
|
|
THRX
3279
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.44M | ﹤0.01% |
+192,047
| New | +$2.44M |
|
|
USX
3280
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $2.43M | ﹤0.01% |
413,406
+27,704
| +7% | +$163K |
|
3281
B2Gold
BTG
$5.94B
| $2.42M | ﹤0.01% |
593,776
-2,260,647
| -79% | -$9.19M |
|
3282
Aterian
ATER
$9.73M
| $2.4M | ﹤0.01% |
48,742
+14,388
| +42% | +$709K |
|
3283
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2.39M | ﹤0.01% |
104,585
-18,525
| -15% | -$424K |
|
|
VIA
3284
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.38M | ﹤0.01% |
41,686
+1,303
| +3% | +$74.5K |
|
3285
Stratus Properties
STRS
$159M
| $2.38M | ﹤0.01% |
65,117
| – | – |
|
|
ZOM
3286
DELISTED
Zomedica Corp.
ZOM
| $2.38M | ﹤0.01% |
7,753,949
-393,399
| -5% | -$121K |
|
|
NBEV
3287
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $2.37M | ﹤0.01% |
2,297,838
+137,774
| +6% | +$142K |
|
3288
ACNB Corp
ACNB
$471M
| $2.37M | ﹤0.01% |
75,638
| – | – |
|
3289
Build-A-Bear
BBW
$977M
| $2.36M | ﹤0.01% |
120,974
+8,475
| +8% | +$165K |
|
|
LHAA
3290
DELISTED
Lerer Hippeau Acquisition Corp. Class A Common Stock
LHAA
| $2.36M | ﹤0.01% |
239,631
+194,891
| +436% | +$1.92M |
|
|
FNA
3291
DELISTED
Paragon 28, Inc.
FNA
| $2.34M | ﹤0.01% |
+132,302
| New | +$2.34M |
|
3292
Evolv Technologies
EVLV
$1.51B
| $2.34M | ﹤0.01% |
523,626
+63,319
| +14% | +$282K |
|
3293
Absci
ABSI
$381M
| $2.33M | ﹤0.01% |
284,452
+91,057
| +47% | +$747K |
|
|
RAIN
3294
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $2.33M | ﹤0.01% |
180,706
+50,755
| +39% | +$654K |
|
|
PFHD
3295
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $2.33M | ﹤0.01% |
121,502
-5
| -0% | -$96 |
|
3296
BCB Bancorp
BCBP
$148M
| $2.32M | ﹤0.01% |
150,412
+572
| +0.4% | +$8.82K |
|
|
EAR
3297
DELISTED
Eargo, Inc. Common Stock
EAR
| $2.32M | ﹤0.01% |
22,735
+13,581
| +148% | +$1.39M |
|
3298
TherapeuticsMD
TXMD
$12.8M
| $2.32M | ﹤0.01% |
130,350
-9,659
| -7% | -$172K |
|
3299
BlackSky Technology
BKSY
$684M
| $2.31M | ﹤0.01% |
+64,254
| New | +$2.31M |
|
3300
SAB Biotherapeutics
SABS
$22.1M
| $2.29M | ﹤0.01% |
+29,341
| New | +$2.29M |
|